GSA CAPITAL PARTNERS LLP - AGILE THERAPEUTICS INC ownership

AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 82 filers reported holding AGILE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of AGILE THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$358,000
-36.5%
733,685
+25.1%
0.04%
-21.1%
Q3 2021$564,000
+13.9%
586,491
+57.4%
0.06%
+1.8%
Q2 2021$495,000
+70.1%
372,543
+166.1%
0.06%
+16.7%
Q1 2021$291,000
-58.0%
140,015
-38.6%
0.05%
-58.6%
Q3 2020$693,000227,8630.12%
Other shareholders
AGILE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 5,062,363$13,617,00018.09%
CAXTON CORP 1,820,012$4,896,0005.95%
Vivo Capital, LLC 1,513,975$4,073,0000.87%
Aisling Capital LLC 1,304,933$3,510,0000.69%
INVESTOR AB 3,510,189$9,442,0000.62%
Perceptive Advisors 3,380,000$9,092,0000.30%
NEEDHAM INVESTMENT MANAGEMENT LLC 408,838$1,099,0000.29%
Broadfin Capital, LLC 358,295$964,0000.16%
FALCON POINT CAPITAL, LLC 63,744$171,0000.03%
Monashee Investment Management LLC 16,411$44,0000.02%
View complete list of AGILE THERAPEUTICS INC shareholders